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Abstract: 
Failure to repair DNA double-stranded breaks leads to cell death. Radiation therapy is
commonly used to kill cancer cells by inducing these breaks. However resistance to radiation
therapy, due to a hyperactive DNA double-stranded break repair pathway, is a common
occurrencethatmakescancerpatientsmorepronetorelapse.TheShieldincomplexisshownto
promote DNA-double stranded break repair by binding to DNA at sites of damage. Thus, the
objective of this project is to understand the affinity and type of DNA that Shieldin binds to,
throughgel-shiftassaysandcomputationalmodeling,fortheeventualcreationofaninhibitorfor
thisproteintostoptheemergenceofradioresistantcancercells. 






Introduction: 
More than 14 million new cases of cancer are diagnosed globally each year, and over
50% of these patients will undergo radiation therapy (RT) [1]. RT induces
DNA double-stranded breaks (DSBs), a cut through both sides of the DNA
backbone resulting in DNA overhangs (Fig. 1) [2]. By creating DSBs, RT
overwhelms cancer cells by blocking theprogressionofDNAreplicationand
causingchromosomaltranslocationswhichcreatesgenomicinstability[2]. 
Unfortunately,resistancetoRTisobservedwithincancercellsduetoanupregulationof
DSB repair pathways [3]. As aresult,thecreationofchemotherapeuticsthattargetDSBrepair
pathway machinery can inhibit cancer cell’s ability to become
radioresistant. 
Our cells have two predominant pathways to repair DSBs:
Homologous Recombination (HR) and Nonhomologous End-Joining
(NHEJ). NHEJ accounts for almost 75% of DSB repairs and works by
ligating/joining DSB blunt ends (Fig. 2). However, NHEJ inaccurately
repairs DSBs by deleting DNA ends (Fig. 2), thus inducing mutagenesis
thatmaycontributetocarcinogenesis[4]. 
NHEJ plays a key role in radioresistant cancer cells since many
proteins specific to NHEJ are over-expressed [5]. Furthermore, due toits
error-prone repair of DSBs (Fig. 2), NHEJ enables cancer cells to
accumulatemutations,furthercontributingtoaradioresistantphenotype.Consequently,proteins
involved in NHEJ are potential chemotherapeutic targets to impair the hyperactivity of this
pathway in radioresistant cancer cells, thus making them more susceptible to RT. This has



previouslybeenattemptedbycreatinginhibitorsformajorNHEJproteinssuchasDNA-PKcsor
DNA Ligase IV. However, these inhibitors had poor specificity and in vivo toxicity hence
preventing clinical application [6]. Therefore, identifying new chemotherapeutic targetswithin
NHEJisnecessary. 
A newly discovered protein,theShieldin(SHLD)complex,promotesNHEJbybinding
to DNA at sites of DSBs through three OB-fold domains on its SHLD2 subunit [7]. By
interactingwithDNA,SHLDactsdownstreamof53BP1andRIF1tocreatetheDNAbluntends
necessary for NHEJ. SHLD prevents exo- and endonucleases involved in HR from resecting
(cuttingawaynucleotides)DNAendswhichprecludesHRfromdominating[8]. 
SHLDisoverexpressedinprostateandtriple-negativebreastcancerpatientsallowingfor
a hyperactive NHEJ pathway [10]. SHLD also plays a key role in the fusion of deprived
telomeres characterizedbyarepetitivesequenceofDNAattheendsofchromosomesthatlook
like damaged DNA, due to the presence of DNA overhangs. This has a causative role in
promoting genomic instability in colon and ovarian cancer tumors. Genetic screens have
identified SHLD as a promoter of radioresistance in cancer cells since it localizes to DSBs
induced by RT. Furthermore, knockout studies report SHLD depleted breast cancer cells are
hypersensitive to RT induced DSBs [9]. Together, this data suggests that inhibiting SHLD’s
abilitytobindtoDNAcouldcreatecancercellssensitizedtoRT. 
SHLD binds DNA through the SHLD2 subunit. In order to create small molecule
inhibitorsforSHLD2,toimpairNHEJandpreventtheonsetofradioresistanceincancercells,it
must be further understood. One gap in knowledge is SHLD2’s preferred DNA substrate (the
typeofDNASHLD2bindstoatDSBs).Studiesthathavetriedtoidentifythisareinconsistentin
their findings. Findlay etal.reportthatSHLD2isproficientinequallybindingtobothdsDNA



andssDNA[9],whileGaoetal.claimSHLD2bindstodsDNAwithahigheraffinityforssDNA
[11]. More importantly, overhang DNA, typically found at DSBs (Fig. 1), and sequence
repetitiveDNAisyettobetested. 
Methods: 
CellCulture- 
4mLofLBwasinoculatedwithacolonyofcellsfromtheLBagarplateand4μLofthe
respectiveantibiotic.Thetubewasplacedinashakerat37°Covernight. 
PlasmidPrep- 
Cellsgrownfroma4mLculturewereformedintoacellpelletina2mLeppendorftube
using a microcentrifuge set to 11,000 rcf for 1 minute. The cell pellet was resuspendedinA1
BufferfromtheNucleoSpinPlasmidPrepKitandlysedusingtheA2buffer.TheA2lysisbuffer
solubilizesthecellmembraneallowingthecellmaterial(hencetheplasmid)tobereleased.The
lysis buffer is neutralized using the A3 buffer and spun down in the microcentrifuge for 20
minutes to separate the soluble and insoluble factions of the cell lysate. The soluble fraction
(whichcontainstheplasmid)isloadedontoasilicamembranecolumnandwashedseveraltimes
withtheAWandA4washbuffersandfinally50μLofelutionwascapturedusingtheAEbuffer.
A1:10dilutionwascreatedbydiluting10μLoftheelutioninto90μLofMilli-Qwater.The280
nmabsorbanceofthedilutionwasreateusinganODspectrophotometertoreadthecontectration
oftheDNAinng/μLandtoassessthepurityoftheelution. 
DNASequencing- 
Inordertodetermineiftheplasmidcontainstherightsequence,teosamplesperplasmid
stock were created each with a concentration of 80 ng/μL. One sample added 5 μL of
petUpstream primer (SEQ) and the other sample added the T7-term primer (5’



GCTAGTTATTGCTCAGCGG3’).Theseprimersbindtotherespectivepartsoftheplasmidto
helpwithsequencing.ThetwosamplesweresenttoGenewizforDNAsequencing.  
PrimerDilutions- 
PrimerswereorderedforIDTinalyophilizedpellet.TheamountofMilli-Qwateradded
toresuspendtheprimerswasdeterminedusingthefollowingequation:[(mg*1000)*6000]/MW.
A1:10dilutionoftheprimerstockwasdoneforlateruse. 
PolymeraseChainReaction(PCR)- 
200 μL PCR tubes consisted of the followingreagents:25μLofMasterMix,1.5μLof
forwardprimer,1.5μLofreverseprimer,1μLoftemplateata5ng/μLconcentration,and21μLof
Milli-Q.TocheckifPCRworked,a0.85%agarosegelwaspreparedbydissolving2μLofSYBR
Safe and 0.3 grams agarose into 35 mL of 0.5X TAEbuffer(Includedcyclesettings).Thegel
was then poured into a tray with a gel comb and polymerized at room temperature for 15
minutes.Samplesfortheagarosegelwerepreparedbymixing10μLofthefinalPCRmixwith
2μLof6XPurpleLoadingDye.Thesampleswerethenloadedontotheagarosegelandrunfor
approximately20minutesafterwhichthegelwasimagedunderaUVlight.  
CellTransformation- 
5 μL of a5ng/uLplasmidstockwerepipettedintocompetentBL21cellsandincubated
onicefor25minutes.Thecellswerethenheatshockedfor45secondsat42°Candthenplaced
onicefor2minutes.Theheatshockedcellswerethenmixedin500μLLBfor1hourat37°C
withshakingandthenspreadontoanLBagarplatewiththerespectiveantibiotic.Theplatewas
incubatedat37°Covernightforcellcoloniestogrow. 






PlasmidCloning- 
TheinsertisamplifiedthroughPCR.Boththeinsertandtheemptyplasmidaredigested
using reaction enzymes with the following regents: 20 μL CutSmart Buffer, 10 μLplasmidor
insert,4μLXhol,4μLBamH,62μLMilli-Qforatotalof100μL.Thenthesamplewascleaned
using a PCR prep kit and only the plasmid was dephosphorylated using 2 μL of rSAP and
incubated at 37°C for 30 minutes and then at 70°C for 20 minutes. The dephosphorylated
plasmid sample was cleaned using a PCR Prep kit and then both the insert and vector were
ligatedusing2μLofT4DNALigaseBuffer,1μLoftheinsert,2μLofthevector,1μLofT4
DNALigase,and14μLofMilli-Q.Theligationwasrunovernightandall20μLoftheligated
plasmid sample was transformed into BL12 cells using the transformation protocol. Colonies
fromthetransformationwereculturedovernightin4mLandthenplasmidpreppedtoextractthe
ligatedplasmidandsentforDNAsequencingtoconfirmcorrectsequence. 
Site-DirectedMutagenesis - 
Primersweredesignedtoeitherdeletepartsofaproteinsequenceortocreateamutation
withinaproteinsequencebytargetingspecificsequenceswithinaplasmid(moredetailaboutthe
specificprimersisintheresultssection).FirstthePCRprotocolwasusedtoamplifythespecific
partoftheplasmidthatwasofinterest.TheamplifiedDNAwasphosphorylatedusing20μLof
Milli-Q, 2.5 μL of T4 DNA ligase buffer, 2 μL of the PCRmix,and0.5μLofT4PNK.This
reaction was incubated at 37°C for 30 minutes and then at 70°C for 20 minutes. The
phosphorylatedwasthenligatedusing13.5μL ofMilli-Q,3.5μLofthephosphorylatedDNA,2
μL ofT4DNALigasebuffer,and1μLofDNAligase.Theligationwasrunfor3-5hoursand
all 20 μL of the ligated plasmid sample was transformed into BL12 cells using the



transformationprotocol.Coloniesfromthetransformationwereculturedovernightin4mLand
then plasmid prepped to extract the ligated plasmid and sent for DNA sequencing to confirm
correctsequence. 
ProteinPurification- 
Transformed cells were cultured into 1L and then spun down at 6000 rpm with a
centrifugetopelletthecells.Thecellpelletisthenresuspendedintoa1xLysisbuffer.300μLof
Triton-X, 300μL of PMSF, and a dash of lysozyme is added to the cellresuspensionwhichis
thensonicatedat15secondsonand45secondsoffonice.Theresultingcelllysateisspundown
at 15000 rpm with a centrifuge. The supertanted isthenfilteredthrougha0.45μMfilterintoa
cobalt matrix column. The column is then placed at 4o C for 25 minutes with shaking. The
solutionthenflowsthroughthecolumnandthematrixiswashedseveraltimes(approx.4)with
1xLysisbufferandthentheproteiniselutedfromthematrixusinganelutionbuffer.Theelution
isthenconcentrateddownto5mLusingtherespectiveAmicontubeandloadedontotheFPLC
with an FPLC buffer (20 mM Tris, 100mM NaCl, 1mM DTT, 2mM EDTA, pH 8.5) for size
exclusionchromatography. 
EMSA- 
12 binding reactions of varying concentrations of protein were created into 20μL. The
concentration ofDNAremainedthesamewhiletheconcentrationofproteinincreased.Varying
amountsof5xBindingBuffer(50µLof1MTris-HCl,pH7.5;10µLof5MNaCl;200µLof1
M KCl, 5 µL of 1 M MgCl2, 10µLof0.5MEDTA,pH8.0;5µLof1MDTT;25µLof10
mg/mL BSA, and 695µLofddH2O[12]).andglycerolwereaddedtomaintainthe20μLtotal
volume.Beforeloadingontoapolyacrylamidegel,4μLof6xEMSAloadingdyewasaddedto
solution and 20μL of the total solution was loaded into the gel. The gel was then run for 5-6



hoursat110Vina1xTBEbuffer(89mMTrisbase,89mMboricacid,1mMEDTA,pH~8.0).
The gel was then stained for DNA diluting 10000XSybrSafein1xTBEbufferwith5μLand
wasleftshakingfor45minutes.ThegelwasthenimagedunderUVlight. 

Results: 
Plasmids- 
In order to carry out any structural studies on SHLD2’s OB fold domains, plasmid
constructencodesthesequenceoftheOB-foldswerecreated. 
A plasmid is a small circular double-stranded DNA that isseparatefromchromosomal
DNA.PlasmidscontaindifferentpartsasshowninFigure1below.Themostimportantaspects
ofaplasmidrelevantforthisstudyaretheinsertedgeneandtheantibioticresistancegene.The
inserted gene encodes the sequence of a
subdomain of SHLD2 C-terminus OB-folds.
Because thisgeneisinserteddownstreamofthe
promoter, the gene will be expressedwithinthe
BL21E.Colicellsthataretransformedwiththe
plasmid. The antibiotic resistance gene allows
for the
selection of cells that havethisplasmid.Thoughcells
aretransformedtotakeuptheplasmid,notallofthem
mighthaveit,asaresultgrowingcellcultureswiththe
presence of an antibiotic that the plasmid confers



resistancetocankillanycellsthatdonothavetheplasmid.  
The plasmid used in this study is the pETDuet vectorshowninFigure2.Thisplasmid
has an ampicillin resistance gene allowing ampicillin to be used as a selective marker. The
pETDuet vector expresses protein with a His-tag on the N-terminus (six histidines atthevery
beginningoftheprotein’sprimarysequence). ThesignificanceofthisHis-tagisdiscussedinthe
proteinpurificationsectionofthisreport. 
OB1: 
The plasmid that encodes SHLD2 OB1 was already in the lab, however it was
resequenced. In order to accomplish thistheOB1plasmidwastransformedintoTop10E.Coli
cells. 
ColoniesfromtheplateoftransformedTop10cellswereculturedinto4mLandplasmid
prepped using the NucleoSpin PlasmidPrepKit. TheconcentrationofOB1extractedwas968
ng/μL. To preparesamplesforDNAsequencing,twosampleseachwithaconcentrationof80
ng/μL of plasmid were made.Whenreadingthesequenceoftheplasmid,onlythesequenceof
the inserted geneisofinterestsincethisiswherethesequenceencodingOB1is.Tomakesure
not the whole plasmid is sequenced andonlytheinsertedgeneis,oneofthetwosamplesread
thesequenceintheforward(5’-3’)directionandtheothersamplewouldreadthesequenceinthe
reverse (3’-5’) direction. 5μL of a pETUpstream primer at a concentration of 166.7 μM was
added to the forward sample. The sequence of the pETUpstream primer is 5’
ATGCGTCCGGCGTAG3’whichbindsrightbeforethesequenceoftheOB1geneallowingfor
sequencingresultstobereadinthe5’-3’direction.TheT7-termprimerisaddedtothe reverse
samplewhichbindsneartheendoftheOB1geneontheplasmidallowingforsequencingresults
tobereadinthe3’-5’direction.ThetwosamplesweresenttoGenewizforsequencingresults. 



Figure 3a and 3b show the forward and reverse sequencing results respectively. Both
sequences were translated into an amino acid sequence using the ExPASY translate tool. The
aminoacidsequenceoftheinsertedgeneisshowninFigure3c.Usingtheblastpmultipleprotein
sequencealignmentsoftware,thisaminoacidsequencewasmappedtotherange427to596on
thefullSHLD2isoform1sequence. 
a)
>3_for-petUpstream_C09.ab1
NNNNNNNNNNNNNNNNCCNNNNNAATNNNTACNACTCACTATAGGNNNNNNGTGAGCGGATAACAATTCCCCTCTAGAAATAATNTTNTTTAACTTTAAGAAGGAGATATA
CCATGGGCAGCAGCCATCACCATCATCACCACAGCCAGGATCCAAAGAAAACGTCATTAATCAAGAACTGCGATTCAAAGAGCCAGAAGTACAATTGCCTGGTCATGGTAT
TGAGCCCTTGCCATGTAAAAGAGATTAACATTAAATTCGGACCAAATTCTGGCTCTAAAGTGCCCTTGGCTACTGTGACCGTAATCGATCAATCCGAAACCAAGAAAAAGG
TATTCCTTTGGCGCACCGCCGCATTCTGGGCGTTTACAGTCTTCCTTGGTGACATCATTTTGTTGACCGACGTCGTGATCCATGAAGATCAATGGATTGGAGAGACTGTAT
TACAATCCACCTTTTCCAGTCAATTGTTGAATCTTGGCTCCTATTCCTCCATTCAGCCTGAGGAATATTCGAGCGTGGTCTCCGAGGTAGTGTTGCAGGACCTTCTTGCAT
ATGTGTCTTCAAAGCATTCATACTTACGCTAACTCGAGTCTGGTAAAGAAACCGCTGCTGCGAAATTTGAACGCCAGCACATGGACTCGTCTACTAGCGCAGCTTAATTAA
CCTAGGCTGCTGCCACCGCTGAGCAATAACTNGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCNGATTGGCGAATG
NNACGCGCCCTGTAGCGGCGCATTAAGCGCGGCGGGTGTGGTGGTTACGCGCANCGTGACCGCTACACTTGCCAGCGCCCTANCGCCCGCTCCTTTCGCTTNCTTCCCTTC
CTTTCTCGCCACNNTCGCCGGCTTTNCCCGNNNAGCTCNAAATCGGGGGCTCCCTTTAGGGTTCCNATTTANTGCTTTACGGCACCNCGACCCCAAAAAATTTGANTNAGG
GTGANGGTTCACGTAATGGGCCA

b)
>4_rev-T7-Term_D09.ab1
NNNNNNNNNNNNNNNNNNNNCTGCGCTAGTAGACNAGTCCATGTGCTGGCGTTCAAATTTCGCAGCAGCGGTTTCTTNACCNGNNTCGAGTTAGCGTAAGTATGAATGCTT
TGAAGACACATATGCAAGAAGGTCCTGCAACACTACCTCGGAGACCACGCTCGAATATTCCTCAGGCTGAATGGAGGAATAGGAGCCAAGATTCAACAATTGACTGGAAAA
GGTGGATTGTAATACAGTCTCTCCAATCCATTGATCTTCATGGATCACGACGTCGGTCAACAAAATGATGTCACCAAGGAAGACTGTAAACGCCCAGAATGCGGCGGTGCG
CCAAAGGAATACCTTTTTCTTGGTTTCGGATTGATCGATTACGGTCACAGTAGCCAAGGGCACTTTAGAGCCAGAATTTGGTCCGAATTTAATGTTAATCTCTTTTACATG
GCAAGGGCTCAATACCATGACCAGGCAATTGTACTTCTGGCTCTTTGAATCGCAGTTCTTGATTAATGACGTTTTCTTTGGATCCTGGCTGTGGTGATGATGGTGATGGCT
GCTGCCCATGGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTCTAGAGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGA
GATCNNTCTCGATCCTCTACGCCGGACGCATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTC
GCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATGGTGGCAGGCCCCGTGGCCGGGGGACTGNTTGGGCGCCATCTCCTTGCATGCACCATTCCNTTGCGGCGGC
GGTGCTCAACGGNCTCAACCTACTACTGGGCTGCTTCCTAATGCAGAGTCGCATANNNNNAGCGTCNAGATCCCGGACACCATCNAATGGCGCAAAANCNTTCGCGGTANN
NGCATGATNNNCGCCCGGAANAAANTCAATTN

c)
MGSSHHHHHHSQDPKKTSLIKNCDSKSQKYNCLVMVLSPCHVKEINIKFGPNSGSKVPLATVTVIDQSETKKKVFLWRTAAFWAFTVFLGDIILLTDVVIHEDQWIGET
VLQSTFSSQLLNLGSYSSIQPEEYSSVVSEVVLQDLLAYVSSKHSYLR

Figure3-OB1plasmidSequencingResults 


Figure 4 shows the secondary structure prediction ofSHLD2fromtheresiduerangeof
427 to 595. This prediction was done usingtheQuick2DsetontheMPIbioinformaticToolkit
software.Quick2Dusestenalgorithmstopredicttheaminoacidlocationsofα-helices(red)and



β-sheets (blue) which are the two primary components of a protein's secondary structure.


FromFigure4,itisclearthattherearefiveβ-sheetsfollowedbyanα-helixmarkeddown
in a black box. These ranges are important because they represent the secondary structure
components of an OB-fold at the general level which is a five-stranded β barrel withoneend
cappedbyanα-helix. 
Boththesequencingresultsandthesecondarystructurepredictionofthemappedregion
onSHLD2’saminoacidsequenceshowthattheplasmidcorrectlyencodesthesequenceoffirst
DNAbindingdomainonSHLD2. 
OB2: 
Like OB1, the plasmid encodingSHLD2OB2wasatthelabbutwasresequenced.The
same process used for OB1wasusedtosequenceOB2.TheconcentrationoftheOB2plasmid
was 906 ng/μLandtheDNAsequencingsampleswerepreparedandsenttoGenewizthesame
wayasOB1. 
a)
>8_rev-T7-Term_H09.ab1


NNNNNNNNNNNNNNNNNNNNNCTGCGCTAGTAGACGAGTCCATGTGCTGGCGTTCAAATTTCGCAGCAGCGGTTTCTTTACCNTACTCGAGTTATGAGGGGGCGGATTTCT
GGAATTTAGCCTTGAAGGTAATAGCGCGGATATCGTCGTCGAAAAGGCATTCACAGCTAGACCAAGGGGTTGTGTGCAATTCCAAATTCTCCAAAGTGTAATTACATTGGA
CAAAAAGGTACTTAAACTCCCAAATGTATCCCTTTTTGCGTTGCAGTTGCGGATACCACGCTGCCCCAGGGCCCCACAGGACTAAGGCATAGTGTTGGTCCTGCGCCTGCT
CTACAGTCAGCATGACCTTTTTCTGCTTTTGTCCGCGATAGCTATAGACAGCTTCGGTAAGGATTGTGAAGTCTACGACGCGAAGAACAGCGTGAACCAGGACATCTGGCT
GCAGGTGTTCTAACTCCACGAAATCAATCGAATTAACTGGATCCTGGCTGTGGTGATGATGGTGATGGCTGCTGCCCATGGTATATCTCCTTCTTAAAGTTAAACAAAATT
ATTTCTAGAGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCGATCTCGATCCTCTACGCCGGACGCATCGTGGCCGGC
ATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTTCGGCGTGGGTATG
GTGGCAGGCCCCGTGGCCGGGGGACTGTTGGGCGCCATCTCCTTGCATGCACCATTCCNTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTGGGCTGCTTCCTAATG
CANGAGTCGCATANGGNANAGCGTCGAGATCNNGGACACCATCGAATNGGCGCAAAACCTTTCGCGGTATGGCNTGNTANCGCCCGGAANANAGTCAATTCANGGTGGNNG
AATGTGNNN
b)MGSSHHHHHHSQDPVNSIDFVELEHLQPDVLVHAVLRVVDFTILTEAVYSYRGQKQKKVMLTVEQAQDQHYALVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLEN
LELHTTPWSSCECLFDDDIRAITFKAKFQKSAPS

Figure5-OB2PlasmidSequencingResults 


Figure 5a shows the sequencing results. The forward sequencing results arenotshown
duetopoorsequencing.TheaminoacidsequencetranslatedfromtheDNAsequence,shownin
Figure 5c, was mapped to the residues 579-707 on the full SHLD2 isoform 1 amino acid



sequence. The secondary structure predictionofthisresiduerangeisshowninFigure6clearly
showsaβbarrelendcappedbyanα-helix.AllofwhichmakeupthestructureofanOB-fold 
ThisdatashowsthattheplasmidcorrectlyencodesthesequenceofthesecondOB-foldof
theSHLD2subunit. 
OB3: 
Like OB1 and OB2, the plasmid encoding SHLD2 OB3 was at the lab but was
resequenced. The same process used for OB1and OB2 was used to sequence OB3. The
concentration of the OB3 plasmid was 818 ng/μL and the DNA sequencing samples were
preparedandsenttoGenewizthesamewayasOB1andOB2. 
a)
>23_for-petUpstream_G11.ab1
NNNNNNNNNNNNNNNNGCNNNNNNNTACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCAT
GGGCAGCAGCCATCACCATCATCACCACAGCCAGGATCCAGTCTACACAGGCTGCGCCAAGTGCGGGTTGGAGCTTGAAACTGATGAGAACCGTATCTATAAGCAATGTTT
TTCCTGCTTGCCATTCACGATGAAGAAAATTTATTACCGTCCGGCGTTGATGACCGCCATCGATGGTCGTCATGATGTGTGTATCCGTGTGGAGTCTAAATTGATTGAAAA
GATCCTTTTGAATATCTCCGCGGATTGCCTTAATCGCGTAATCGTCCCATCCAGCGAAATTACCTACGGTATGGTAGTTGCTGACTTGTTTCATAGCCTTCTGGCTGTTTC
TGCTGAACCATGCGTGTTGAAAATCCAGTCTTTGTTTGTTTTAGACGAGAATTCATATCCTCTTCAGCAGGATTTTAGTCTTCTTGACTTCTACCCCGATATCGTGAAGTA
ACTCGAGTCTGGTAAAGAAACCGCTGCTGCGAAATTTGAACGCCAGCACATGGACTCGTCTACTAGCGCAGCTTAATTAACCTAGGCTGCTGCCACCGCTGAGCAATAACT
AGCATAACCCCTTGGGGCCTCTAAACGGGTCTTGAGGGGTTTTTTGCTGAAAGGAGGAACTATATCCGGATTGGCGAATGGGACGCGCCCTGTAGCGGCGCATTAAGCGCG
GCGGGTGTGGTGGTTACGCGCAGCGTGACCGCTACACTTGCCAGCGCCCTANCGCCCGCTCCTTTCGCTTTCTTCCCTTCCTTTCTCGCCACGTTCGCCGGCTTTCCCCGT
CAAGCTCTAAATCGGGGGCTCCCTTTANGGTTCCGATTTAGTGCTTTACGGCNCCTCGACCCCAAAAAACTTGATNNNGTGATGGN
b)
>24_rev-T7-Term_H11.ab1
NNNNNNNNNNNNNANNAAGCTGCGCTAGTAGACGAGTCCATGTGCTGGCGTTCAAATTTCGCAGCAGCGGTTTCTTNANNNGACTCGAGTTACTTCACGATATCGGGGTAG
AAGTCAAGAAGACTAAAATCCTGCTGAAGAGGATATGAATTCTCGTCTAAAACAAACAAAGACTGGATTTTCAACACGCATGGTTCAGCAGAAACAGCCAGAAGGCTATGA
AACAAGTCAGCAACTACCATACCGTAGGTAATTTCGCTGGATGGGACGATTACGCGATTAAGGCAATCCGCGGAGATATTCAAAAGGATCTTTTCAATCAATTTAGACTCC
ACACGGATACACACATCATGACGACCATCGATGGCGGTCATCAACGCCGGACGGTAATAAATTTTCTTCATCGTGAATGGCAAGCAGGAAAAACATTGCTTATAGATACGG
TTCTCATCAGTTTCAAGCTCCAACCCGCACTTGGCGCAGCCTGTGTAGACTGGATCCTGGCTGTGGTGATGATGGTGATGGCTGCTGCCCATGGTATATCTCCTTCTTAAA
GTTAAACAAAATTATTTCTAGAGGGGAATTGTTATCCGCTCACAATTCCCCTATAGTGAGTCGTATTAATTTCGCGGGATCGAGATCGATCTCGATCCTCTACGCCGGACG
CATCGTGGCCGGCATCACCGGCGCCACAGGTGCGGTTGCTGGCGCCTATATCGCCGACATCACCGATGGGGAAGATCGGGCTCGCCACTTCGGGCTCATGAGCGCTTGTTT
TCGGCGTGGGTATGGTGGCAGGNCCCGTGGCCGGGGGACTGTTGGGCGCCATCNTCCTTGCATGCACCATTCCTTGCGGCGGCGGTGCTCAACGGCCTCAACCTACTACTG
GGCTGCTTCCTATNGCANGAGTCGCATAAGGGAGAGCGTCGAGATCCCGGACACCATCGAATGGCGCAAAACCTTTCNCGGTATNGNNN
c)MGSSHHHHHHSQDPVYTGCAKCGLELETDENRIYKQCFSCLPFTMKKIYYRPALMTAIDGRHDVCIRVESKLIEKILLNISADCLNRVIVPSSEITYGMVVADLFHSLL
AVSAEPCVLKIQSLFVLDENSYPLQQDFSLLDFYPDIVK

Figure7-OB3SequencingResults 



Figure7aand7bshowtheforwardandreversesequencingresultsrespectively.Theaminoacid
sequence resulting from translating the DNA sequence shown in Figure 6cmapstotheamino
acidrangeof764-897ofSHLD2. 
Figure 8showsthesecondarystructurepredictionofthisresiduerange.Thoughthekey
features of an OB-fold secondary structure are not as apparent as OB1 and OB2 it is not as
obviousinOB3.TheimplicationsofthisarefurtherdiscussedduringthepurificationofOB3. 


OB123: 
To make the plasmidthatencodesthefullC-terminusOB-foldsofSHLD2,theplasmid
cloning protocol described in the methods section was used. Figure 9a briefly describes how
cloningworks.  
First an emptyvectoranda
target gene are acquired. For the
creation of the OB123 plasmid,an
empty pETDuet vector was used
and a dsDNA fragment that



encodedthesequenceofSHLD2OB123wasusedasthetargetgene. 
FromFigure2,itisclearthatthepETDuetvectorhasmanyrestrictionenzymecutsites.
A restriction enzyme cleaves dsDNA at specific sites/sequences. Therestrictionenzymesused
wereBamHIandXhoI.Figure9bshowsthedsDNAcutesitethattheseenzymesrecognizeand
how they cut the dsDNA. BamHI and XhoI generate DNA sticky ends when cutting dsDNA.
Sticky ends refers to the presence of a few unpaired nucleotides attheendofdsDNA.Thisis
importantbecauseboththeemptypETDuetvectorandtheOB123DNAfragmenteachcontaina
BamHI and XhoI recognition site. As a result, the OB123 fragment and the empty pETDuet
vectorhavecompatibleDNAstickyends.Figure12betterrepresentsthiscrucialidea.Whentwo
fragmentsofDNAarecutbythesamerestrictionenzymetheirstickyendsarecomplementary. 
To accomplish this the OB123 DNA insert was amplified throughPCR,andtheempty
vectorandinsertweredigestedwithBamHIandXhoI. 
TheplasmidonlywasthendephosphorylatedusingShrimpAlkalinePhosphatase(rSAP).
When digestingtheplasmid,the5’endsstillremainphosphorylated,thusallowingtheplasmid
tore-circulizewithouttheinsertedgene. Bydephosphorylatingtheplasmid,rSAPremovesthe
phosphategroupsattachedtothe5’endsoftheplasmidDNA. 
However the phosphate groups still remain onthe5’endsoftheOB123fragmentafter
digestion, the fragment can be inserted into the plasmid through the use of T4 DNA ligase.
Figure 10 shows how DNA
ligase accomplishes this. DNA
ligase forms a phosphodiester
bond between the 3’ hydroxyl



groupoftheplasmidandthe5’phosphateoftheinsert. 
a)
>3_for-petUpstream_C05.ab1
(for)
NNNNNNGNNCNNNAATNNNACGACTCNCTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGGGCAGC
AGCCATCACCATCATCACCACAGCCAGGATCCAAAGAAAACGTCATTAATCAAGAACTGCGATTCAAAGAGCCAGAAGTACAATTGCCTGGTCATGGTATTGAGCCCTTGC
CATGTAAAAGAGATTAACATTAAATTCGGACCAAATTCTGGCTCTAAAGTGCCCTTGGCTACTGTGACCGTAATCGATCAATCCGAAACCAAGAAAAAGGTATTCCTTTGG
CGCACCGCCGCATTCTGGGCGTTTACAGTCTTCCTTGGTGACATCATTTTGTTGACCGACGTCGTGATCCATGAAGATCAATGGATTGGAGAGACTGTATTACAATCCACC
TTTTCCAGTCAATTGTTGAATCTTGGCTCCTATTCCTCCATTCAGCCTGAGGAATATTCGAGCGTGGTCTCCGAGGTAGTGTTGCAGGACCTTCTTGCATATGTGTCTTCA
AAGCATTCATACTTACGCGATCTGCCGCCTCGCCAACCGCAACGCGTTAATTCGATTGATTTCGTGGAGTTAGAACACCTGCAGCCAGATGTCCTGGTTCACGCTGTTCTT
CGCGTCGTAGACTTCACAATCCTTACCGAAGCTGTCTATAGCTATCGCGGACAAAAGCAGAAAAAGGTCATGCTGACTGTAGAGCAGGCGCAGGACCAACACTATGCCTTA
GTCCTGTGGGGCCCTGGGGCAGCGTGGTATCCGCAACTGCAACGCAAAAAGGGATACATTTGGGAGTTTAAGTACCTTTTTGTCCAATGTAATTACACTTTGGAGAATTTG
GAATTGCACACAACCCCTTGGTCTAGCTGTGAATGCCTTTTCGACGACGATATCCGCGCTATTACCTTCAAGGCTAAATTCCAGAAATCCGCCCCCTCATTTGTAAAATCA
GCGATCTGGCANNACACCTNNNNNAANTGNTCCGNTGNNGTATNATCAAGCNCAGATTANCGAATTGGNGTTCCCGATTAN
b)MGSSHHHHHHSQDPKKTSLIKNCDSKSQKYNCLVMVLSPCHVKEINIKFGPNSGSKVPLATVTVIDQSETKKKVFLWRTAAFWAFTVFLGDIILLTDVVIHEDQWIGET
VLQSTFSSQLLNLGSYSSIQPEEYSSVVSEVVLQDLLAYVSSKHSYLRDLPPRQPQRVNSIDFVELEHLQPDVLVHAVLRVVDFTILTEAVYSYRGQKQKKVMLTVEQAQD
QHYALVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKSAIWXXTXXXXSXXVXSSXDXRIXVPDX
c)
>4_rev-T7-Term_D05.ab1
(rev)
NNNNNNNNNNNNNNCTGCGCTAGTAGACGAGTCCATGTGCTGGCGTTCAAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTTACTTCACGATATCGGGGTAGAAGTC
AAGAAGACTAAAATCCTGCTGAAGAGGATATGAATTCTCGTCTAAAACAAACAAAGACTGGATTTTCAACACGCATGGTTCAGCAGAAACAGCCAGAAGGCTATGAAACAA
GTCAGCAACTACCATACCGTAGGTAATTTCGCTGGATGGGACGATTACGCGATTAAGGCAATCCGCGGAGATATTCAAAAGGATCTTTTCAATCAATTTAGACTCCACACG
GATACACACATCATGACGACCATCGATGGCGGTCATCAACGCCGGACGGTAATAAATTTTCTTCATCGTGAATGGCAAGCAGGAAAAACATTGCTTATAGATACGGTTCTC
ATCAGTTTCAAGCTCCAACCCGCACTTGGCGCAGCCTGTGTAGACAATATTCGGCAAAGAGGAAAAAATGCTTTTAAGTGACGAGTGGGCGTTTAACGCGATCTTCTGACT
TGCGGTAATCGGGAACGCCAATTCGCTAATCTGCGCTTTGATCAATACAACACCGGAACATTTGTCCTCCAGGTGTGTTGCCAGATCGCTGATTTTTACAAATGAGGGGGC
GGATTTCTGGAATTTAGCCTTGAAGGTAATAGCGCGGATATCGTCGTCGAAAAGGCATTCACAGCTAGACCAAGGGGTTGTGTGCAATTCCAAATTCTCCAAAGTGTAATT
ACATTGGACAAAAAGGTACTTAAACTCCCAAATGTATCCCTTTTTGCGTTGCAGTTGCGGATACCACGCTGCCCCAGGGCCCCACAGGACTAAGGCATAGTGTTGGTCCTG
CGCCTGCTCTACAGTCAGCATGACCTTTTTCTGCTTTTGTCCGCGATAGCTATAGACAGCTTCGGTANGGATTGTGAAGTCTACGACGCGAAGAACAGCGTGAACCAGGAC
ATCTGGCTGCNGNNGTTCTAACTCCACGAAATCAATCGAATTAACGCGTTGCGGTTGGNGAGGCG
d)MLTVEQAQDQHYALVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKISDLATHLEDKCSGVVLIKAQI
SELAFPITASQKIALNAHSSLKSIFSSLPNIVYTGCAKCGLELETDENRIYKQCFSCLPFTMKKIYYRPALMTAIDGRHDVCIRVESKLIEKILLNISADCLNRVIVPSSE
ITYGMVVADLFHSLLAVSAEPCVLKIQSLFVLDENSYPLQQDFSLLDFYPDIVK
e)MGSSHHHHHHSQDPKKTSLIKNCDSKSQKYNCLVMVLSPCHVKEINIKFGPNSGSKVPLATVTVIDQSETKKKVFLWRTAAFWAFTVFLGDIILLTDVVIHEDQWIGET
VLQSTFSSQLLNLGSYSSIQPEEYSSVVSEVVLQDLLAYVSSKHSYLRDLPPRQPQRVNSIDFVELEHLQPDVLVHAVLRVVDFTILTEAVYSYRGQKQKKVMLTVEQAQD
QHYALVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKISDLATHLEDKCSGVVLIKAQISELAFPITASQ
KIALNAHSSLKSIFSSLPNIVYTGCAKCGLELETDENRIYKQCFSCLPFTMKKIYYRPALMTAIDGRHDVCIRVESKLIEKILLNISADCLNRVIVPSSEITYGMVVADLF
HSLLAVSAEPCVLKIQSLFVLDENSYPLQQDFSLLDFYPDIVK

Figure11-OB123SequencingResults 


After the dephosphorylated plasmidwasligatedwiththeOB123insert,itwastransformedinto
Top10cellsandcoloniesfromtheplatewereculturedinto4mLandplasmidpreppedusingthe



NucleoSpinPlasmidPrepKit.TheconcentrationoftheextractedOB123plasmidwas91ng/μL.
The DNA sequencing samples were prepared the same way as OB1 and sent to Genewiz for
results. 
ThesequenceoftheOB123plasmidisshowninFigure11.Aninterestingresultseenin
the sequencing resultisthatboththeforwardandreversesequences(13aand13crespectively) 
are different. This is because the DNA sequence is too long for both the pETUpstream and
T7-termprimerstoreadthewholesequence.Figure11eshowsthefullsequenceoftheinserted
gene which maps to therange427-897ontheSHLD2aminoacidsequence.Thisrangecovers
allthreeOB-folddomainsthusconfirmingthesuccessfulcreationoftheOB123plasmid. 
OB12: 
ThecreationoftheOB12plasmidusedatechnique
calledsite-directedmutagenesis.Thisprocesscanaddor
delete DNA nucleotides from a plasmid. Bybeingable
to add or delete nucleotides, the original amino acid
sequence of the plasmid is also altered because every
three DNA nucleotides, called a codon, directly
translates into a specific amino acid. Since the OB123
plasmid previously created has the sequence for the
desiredOB12plasmid,thistechniquewasusedtoadda
stop codon to the end of OB12 on the OB123 plasmid
(showninredinFigure12). Byaddingastopcodon(5’
TAA 3’) here, only OB12 will be expressed from the
OB123plasmidsincethecodonterminatesbeforeOB3canbetranslated. 



To accomplishthisPCRwasfirstusedtoamplifytheDNAplasmidthat,aforward(5’
AAgttgtattgatcaaagcgcagatt 3’) and reverse (5’ Aaccggaacatttgtcctcc 3’) primer were created
bothofwhichboundtotheendofOB2ontheOB123plasmid(showninredinfigure12).The
DNAsequencehighlightedinyellowencodingtheendofOB2andthesequencehighlightedin
blueencodingthebeginningofOB3.Theprimersaredesignedtobindatthisjunction.Themost
important characteristic of these primers is that the DNA sequence (stop-codon) that is being
insertedatthisjunctiondoesnotbindtotheDNA.However,thesenucleotidesthatdonotbind
getincorporatedintotheoverallplasmidsequenceoncetheDNAisreplicated.Aftertheprimers
bindandarereplicatedwithinthePCR,theendsoftheprimersthatinitiallydonotbindarealso
replicated;thisresultsinalonglineardsDNAstrand.TomakethislinearDNAcirculartoforma
plasmidthe5’endswerephosphorylatedusingT4PNKandligatedusingT4DNAligase.Inthe
finalresult,noticethatthestopcodonisrightaftertheendofOB2andrightbeforethebeginning
ofOB3,thusindicatingthatexpressionofthegenewillbeterminatedaftertranslatingOB12. 
a)
>1_for-petUpstream_A01.ab1
NNNNNNNNNNNNNCNNNNNNNAATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGG
GCAGCAGCCATCACCATCATCACCACAGCCAGGATCCAAAGAAAACGTCATTAATCAAGAACTGCGATTCAAAGAGCCAGAAGTACAATTGCCTGGTCATGGTATTGAGCC
CTTGCCATGTAAAAGAGATTAACATTAAATTCGGACCAAATTCTGGCTCTAAAGTGCCCTTGGCTACTGTGACCGTAATCGATCAATCCGAAACCAAGAAAAAGGTATTCC
TTTGGCGCACCGCCGCATTCTGGGCGTTTACAGTCTTCCTTGGTGACATCATTTTGTTGACCGACGTCGTGATCCATGAAGATCAATGGATTGGAGAGACTGTATTACAAT
CCACCTTTTCCAGTCAATTGTTGAATCTTGGCTCCTATTCCTCCATTCAGCCTGAGGAATATTCGAGCGTGGTCTCCGAGGTAGTGTTGCAGGACCTTCTTGCATATGTGT
CTTCAAAGCATTCATACTTACGCGATCTGCCGCCTCGCCAACCGCAACGCGTTAATTCGATTGATTTCGTGGAGTTAGAACACCTGCAGCCAGATGTCCTGGTTCACGCTG
TTCTTCGCGTCGTAGACTTCACAATCCTTACCGAAGCTGTCTATAGCTATCGCGGACAAAAGCAGAAAAAGGTCATGCTGACTGTAGAGCAGGCGCAGGACCAACACTATG
CCTTAGTCCTGTGGGGCCCTGGGGCAGCGTGGTATCCGCAACTGCAACGCAAAAAGGGATACATTTGGGAGTTTAAGTACCTTTTTGTCCAATGTAATTACACTTTGGAGA
ATTTGGAATTGCACACAACCCCTTGGTCTAGCTGTGAATGCCTTTTCGACGACGATATCCGCGCTATTACCTTCAAGGCTAAATTCCAGAAATCCGCCCNCT
b)MGSSHHHHHHSQDPKKTSLIKNCDSKSQKYNCLVMVLSPCHVKEINIKFGPNSGSKVPLATVTVIDQSETKKKVFLWRTAAFWAFTVFLGDIILLTDVVIHEDQWIGET
VLQSTFSSQLLNLGSYSSIQPEEYSSVVSEVVLQDLLAYVSSKHSYLRDLPPRQPQRVNSIDFVELEHLQPDVLVHAVLRVVDFTILTEAVYSYRGQKQKKVMLTVEQAQD
QHYALVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAX
Iso1:
427
-
705
c)NNNNNNNNNNNNNNNANCTGCGCTAGTAGACGAGTCCATGTGCTGGCGTTCAAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTTACTTCACGATATCGGGGTAG
AAGTCAAGAAGACTAAAATCCTGCTGAAGAGGATATGAATTCTCGTCTAAAACAAACAAAGACTGGATTTTCAACACGCATGGTTCAGCAGAAACAGCCAGAAGGCTATGA
AACAAGTCAGCAACTACCATACCGTAGGTAATTTCGCTGGATGGGACGATTACGCGATTAAGGCAATCCGCGGAGATATTCAAAAGGATCTTTTCAATCAATTTAGACTCC
ACACGGATACACACATCATGACGACCATCGATGGCGGTCATCAACGCCGGACGGTAATAAATTTTCTTCATCGTGAATGGCAAGCAGGAAAAACATTGCTTATAGATACGG


TTCTCATCAGTTTCAAGCTCCAACCCGCACTTGGCGCAGCCTGTGTAGACAATATTCGGCAAAGAGGAAAAAATGCTTTTAAGTGACGAGTGGGCGTTTAACGCGATCTTC
TGACTTGCGGTAATCGGGAACGCCAATTCGCTAATCTGCGCTTTGATCAATACAACTTAACCGGAACATTTGTCCTCCAGGTGTGTTGCCAGATCGCTGATTTTTACAAAT
GAGGGGGCGGATTTCTGGAATTTAGCCTTGAAGGTAATAGCGCGGATATCGTCGTCGAAAAGGCATTCACAGCTAGACCAAGGGGTTGTGTGCAATTCCAAATTCTCCAAA
GTGTAATTACATTGGACAAAAAGGTACTTAAACTCCCAAATGTATCCCTTTTTGCGTTGCAGTTGCGGATACCACGCTGCCCCAGGGCCCCACAGGACTNANNNATAGTGT
TGGTCCTGCGCCTGCTCTACAGTCAGCATGACCTTTTTCTGCTTTTGTCCGCGATAGCTATAGACAGCTTCGGTAAAGGATTGTGAAGTCTACGACGCGAAGAACNN
d)
MLTVEQAQDQHYXXVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKISDLATHLEDKCSG
Iso1:
624
-
724
e)MGSSHHHHHHSQDPKKTSLIKNCDSKSQKYNCLVMVLSPCHVKEINIKFGPNSGSKVPLATVTVIDQSETKKKVFLWRTAAFWAFTVFLGDIILLTDVVIHEDQWIGET
VLQSTFSSQLLNLGSYSSIQPEEYSSVVSEVVLQDLLAYVSSKHSYLRDLPPRQPQRVNSIDFVELEHLQPDVLVHAVLRVVDFTILTEAVYSYRGQKQKKVMLTVEQAQD
QHYXXVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKISDLATHLEDKCSG

Figure13-OB12SequencingResults 

Figure13showsthesequencingoftheplasmidafteritwasextractedfroma4mLculture.
LikethesequencingresultsfromtheOB123plasmid,theforwardandreversesequencingresults
overlapwithFigure16eshowingthefullaminoacidsequence.Thesequencemapstotherange
427-724 on the full SHLD2 sequence, thus confirming the successful creation of the OB12
plasmid. 
OB23: 
Site-directed mutagenesis was also used in the creation of the OB23 plasmid.
Conceptually it is very similar however instead of adding DNA nucleotides to the plasmid,
nucleotides that encoded the OB1 domain were deleted from the OB123 plasmid through
specificallydesignedprimers. 
The forward primer (5’ CGCGATCTGCCGCCTCG 3’) binds to theOB123plasmidat
the endofOB1andthereverseprimer(5’CTGGCTGTGGTGATGATGGTGATGGC3’)binds
totheOB123plasmidtothebeginningofOB1.Thesameprocessdiscussedaboveoccurswhich
effectivelydeletesOB1andtheresultingplasmidencodedOB23. 







a)NNNNNNNNNNNCGCNANNTNATACGACTCACTATAGGGGAATTGTGAGCGGATAACAATTCCCCTCTAGAAATAATTTTGTTTAACTTTAAGAAGGAGATATACCATGG
GCAGCAGCCATCACCATCATCACCACAGCCAGGATCAGGACCTTCTTGCATATGTGTCTTCAAAGCATTCATACTTACGCGATCTGCCGCCTCGCCAACCGCAACGCGTTA
ATTCGATTGATTTCGTGGAGTTAGAACACCTGCAGCCAGATGTCCTGGTTCACGCTGTTCTTCGCGTCGTAGACTTCACAATCCTTACCGAAGCTGTCTATAGCTATCGCG
GACAAAAGCAGAAAAAGGTCATGCTGACTGTAGAGCAGGCGCAGGACCAACACTATGCCTTAGTCCTGTGGGGCCCTGGGGCAGCGTGGTATCCGCAACTGCAACGCAAAA
AGGGATACATTTGGGAGTTTAAGTACCTTTTTGTCCAATGTAATTACACTTTGGAGAATTTGGAATTGCACACAACCCCTTGGTCTAGCTGTGAATGCCTTTTCGACGACG
ATATCCGCGCTATTACCTTCAAGGCTAAATTCCAGAAATCCGCCCCCTCATTTGTAAAAATCAGCGATCTGGCAACACACCTGGAGGACAAATGTTCCGGTGTTGTATTGA
TCAAAGCGCAGATTAGCGAATTGGCGTTCCCGATTACCGCAAGTCAGAAGATCGCGTTAAACGCCCACTCGTCACTTAAAAGCATTTTTTCCTCTTTGCCGAATATTGTCT
ACACAGGCTGCGCCAAGTGCGGGTTGGAGCTTGAAACTGATGAGAACCGTATCTATAAGCAATGTTTTTCCTGCTTGCCATTCACGATGAAGAAAATTTATTACCGTCCGG
CGTTGATGACCGCCATCGATGGTCGTCATGATGTGTGTATCCGTGTGGAGTCTAAATTGATTGAAAAGATCCTTTTGAATATCTCCGCGGATTGCCTTAATCGCGTAATCG
TCCCATCCAGCGAAATTACCTACGGTATGGNAGTTGCTGACTTGNTTCNNAGCCTTCTGGCTGNTTNNTGCNN
b)MGSSHHHHHHSQDQDLLAYVSSKHSYLRDLPPRQPQRVNSIDFVELEHLQPDVLVHAVLRVVDFTILTEAVYSYRGQKQKKVMLTVEQAQDQHYALVLWGPGAAWYPQL
QRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKISDLATHLEDKCSGVVLIKAQISELAFPITASQKIALNAHSSLKSIFSSLP
NIVYTGCAKCGLELETDENRIYKQCFSCLPFTMKKIYYRPALMTAIDGRHDVCIRVESKLIEKILLNISADCLNRVIVPSSEITYGMXVADLXXSLLAXXC
c)NNNNNNNNNNNNNNAGCTGCGCTAGTAGACGAGTCCATGTGCTGGCGTTCAAATTTCGCAGCAGCGGTTTCTTTACCAGACTCGAGTTACTTCACGATATCGGGGTAGA
AGTCAAGAAGACTAAAATCCTGCTGAAGAGGATATGAATTCTCGTCTAAAACAAACAAAGACTGGATTTTCAACACGCATGGTTCAGCAGAAACAGCCAGAAGGCTATGAA
ACAAGTCAGCAACTACCATACCGTAGGTAATTTCGCTGGATGGGACGATTACGCGATTAAGGCAATCCGCGGAGATATTCAAAAGGATCTTTTCAATCAATTTAGACTCCA
CACGGATACACACATCATGACGACCATCGATGGCGGTCATCAACGCCGGACGGTAATAAATTTTCTTCATCGTGAATGGCAAGCAGGAAAAACATTGCTTATAGATACGGT
TCTCATCAGTTTCAAGCTCCAACCCGCACTTGGCGCAGCCTGTGTAGACAATATTCGGCAAAGAGGAAAAAATGCTTTTAAGTGACGAGTGGGCGTTTAACGCGATCTTCT
GACTTGCGGTAATCGGGAACGCCAATTCGCTAATCTGCGCTTTGATCAATACAACACCGGAACATTTGTCCTCCAGGTGTGTTGCCAGATCGCTGATTTTTACAAATGAGG
GGGCGGATTTCTGGAATTTAGCCTTGAAGGTAATAGCGCGGATATCGTCGTCGAAAAGGCATTCACAGCTAGACCAAGGGGTTGTGTGCAATTCCAAATTCTCCAAAGTGT
AATTACATTGGACAAAAAGGTACTTAAACTCCCAAATGTATCCCTTTTTGCGTTGCAGTTGCGGATACCACGCTGCCCCAGGGCCCCACAGGACTNANNNATAGTGTTGGT
CCTGCGCCTGCTCTACAGTCAGCATGACCTTTTTCTGCTTTTGTCCGCGATAGCTATAGACAGCTTCGGTAAGNATTGTGAAGTCTACGACGCGAAGAACAGCGTGAACCA
GGACATCTGGCTGNN
d)MLTVEQAQDQHYXXVLWGPGAAWYPQLQRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKISDLATHLEDKCSGVVLIKAQI
SELAFPITASQKIALNAHSSLKSIFSSLPNIVYTGCAKCGLELETDENRIYKQCFSCLPFTMKKIYYRPALMTAIDGRHDVCIRVESKLIEKILLNISADCLNRVIVPSSE
ITYGMVVADLFHSLLAVSAEPCVLKIQSLFVLDENSYPLQQDFSLLDFYPDIVK
e)MGSSHHHHHHSQDQDLLAYVSSKHSYLRDLPPRQPQRVNSIDFVELEHLQPDVLVHAVLRVVDFTILTEAVYSYRGQKQKKVMLTVEQAQDQHYXXVLWGPGAAWYPQL
QRKKGYIWEFKYLFVQCNYTLENLELHTTPWSSCECLFDDDIRAITFKAKFQKSAPSFVKISDLATHLEDKCSGVVLIKAQISELAFPITASQKIALNAHSSLKSIFSSLP
NIVYTGCAKCGLELETDENRIYKQCFSCLPFTMKKIYYRPALMTAIDGRHDVCIRVESKLIEKILLNISADCLNRVIVPSSEITYGMVVADLFHSLLAVSAEPCVLKIQSL
FVLDENSYPLQQDFSLLDFYPDIVK

Figure14-OB23SequencingResults 

Figure14aand14bshowsthesequencingresultsfortheforwardandreverseprimers.14e
showsthetranslatedsequenceanditmapsto555-897ofSHLD2whichcontainsbothOB2and
OB3,thusconfirmingthesuccessfulcreationoftheOB23plasmid. 




ProteinPurification: 
OB1: 
The purpose of protein purification is to isolate a protein of interestfromallothercell
material. In order to accomplish this,theplasmidthatencodestheprotein,inthiscaseOB1,is
used.Bacterialcellswilltakeplasmidandexpressittoproducetheprotein.Onereasonwhythis
is important is because human OB1 is not naturally expressed in bacterial cells, thus using a
plasmid allows for the production of OB1. Moreimportantly,theOB1plasmidexpressesOB1
with a His-tag on itsN-terminus(sixhistidines).ThesequencingresultsforOB1showsthisin
Figure 3. The significance of this
willbediscussedshortly. 
BL21 E. Coli cells were
transformed

with

the

pETDuet-OB1plasmid.BL21cells
are used instead of Top10 cells
because BL21 cells transcribe a
proteincalledT7RNApolymerase
[13].

This

polymerase helps

express other genes, like that
encoded on the plasmid, 8 times
faster than normal E. Coli cells
[13]. Furthermore that gene that
encodes T7 RNA polymerase is



undercontrolofthelacUV5promoter(PlacUV5),whichisastrongvariantofthewild-typelac
promoter[13],thusallowingfortightcontroloverwhentheOB1plasmidisexpressed. 
A colony of the transformed BL21 cells were cultured into 1 L of litrobroth until the
OD600 reading reached 0.8 at which point protein expression was induced with
isopropyl-β-D-1-thiogalactopyranoside IPTG. By adding IPTG, the gene encoding T7 RNA
polymerase is expressed and the polymerase recognizes the T7 promoters on the pETDuet
vector,thusinitiatingtheexpressionoftheprotein,OB1. 
Afterinduction,thecellsweregrownovernightandspundownintoacellpelletusinga
centrifuge.Thecellswerethenresuspendedinto45mLof1xlysisbuffer.Atthispoint,thecells
shouldhavetheOB1domainexpressed.ThisideaisillustratedinFigure15.Thisfigureshows
anSDS-PAGEgelofthedifferentstepsofproteinpurificationdescribedinthemethodssection.
AnSDS-PAGEgelisusedtoseparateproteinsbasedonmolecularweight,thusallowingforthe
detection of specific proteins. Since the OB1 domain is 17.7 kDa, presence of OB1 wouldbe
seen in the SDS-PAGE gel at that molecular weight. Lane 3 showsthegelsampleforthecell
culture before adding IPTG. There is clearly no band at the 17.7 kDa mark as expectedsince
protein expression was not induced. However Lane 4 shows a sample of the cellcultureonce
IPTG is added and resuspended in the 1x lysis buffer. There is protein at the 17.7 kDa mark
whichconfirmsproteininduction. 
After the cells were resuspended, they were sonicated. Sonication rupures cell
membranesthusallowingforthecellproteinstobecomereleasedinsolution.Lane5ofthegel
infigure15showsthissincethereseemstobemoreproteininthelane,andproteinispresentat
the17.7kDamarkshowingthatOB1ispresentinthesonicatedcelllysate.  



This cell lysate was then spun down using a centrifuge set to 15000 rpm for 1 hr. By
spinning down this lysate, the insoluble and soluble fractions are separated by pelting the
insoluble cell material. This insoluble material includes phospholipids or even
insoluble/aggregatedprotein.Lanes6and7ofthegelshowthesolubleandinsolublefractionsof
the spun down cell lysate. Seeing that there is a lot of protein present in the soluble fraction
(especially at the 17.7 kDamark)showsthattheOB1proteinisinthesolublefraction.Thisis
importantbecauseitallowsfortheselectivepurificationofOB1fromthesolublefraction.OB1
is expressed with 6 histidines bonded to the N-terminus of its amino acid sequence (refer to
sequencing results in Figure 3). No other protein in the soluble cell lysatehasthistypeoftag
thus allowing theusageofamethodthatselectsforproteinswiththeHis-tagwhichisonlythe
OB1protein. 
ThemethodusediscalledImmobilizedMetalAffinityChromatography(IMAC). IMAC
isusedbecausepurificationofHis-taggedproteinsbyIMACisbasedontheaffinityofhistidine
residues for immobilized metal ions. The cobalt metal ion, Co2+, is immobilized onto a
chromatographicmatrix,asaresult,anyHis-tagthatisinthepresenceofthismatrixwillbindto
the Co2+ since histidine has a high affinity with immobilized metal ion matrices, as electron
donor groups on the histidine imidazole ring readily form coordination bonds with the
immobilized transitionmetal(Co2+)[14].UsingaCo2+resincancapturealltheOB1proteins
sincetheyallhaveaHis-tagthatcanbindtothematrixwhereasotherproteinsmaynotbeable
to. 
Toaccomplishthis,thesolublecelllysatewasfilteredontoapurificationcolumnwith5
mLofCo2+ resinwitha0.45micrometerfilter.Thenthefilteredsolutionwasincubatedwiththe
Co2+ resinat4celsiusfor25minuteswithshaking.Thisallowsthehis-taggedOB1tobindtothe



matrix. After the 25 min incubation, the remaining solution is allowed to flow through the
matrix.Thisflowthroughcontainsallthesolubleproteinsthatdonotbindtothecobaltmatrix.It
ishoweverpossibletohaveproteinsbindtothematrixthroughnonspecificinteractions.Thisis
becauseproteinscontainingconsecutivehistidinesormetal-bindingmotifsthatarenotOB1can
bind to the matrix. Togetridoftheseproteinsthematrixiswashedmultipletimeswiththe1x
lysis buffer which contains 0.01M of imidazole. Imidazole has a higher affinity for Co2+ than
histidine, thus displacing these nonspecifically bound proteins fromthematrix.Thisimidazole
concentrationistoolowtodisplacemuchoftheboundOB1sincetheproteinisoverexpressed.
To elute OB1 off the column, an elution buffer with 0.5M concentration ofimidazoleisused.
ThiseffectivelydisplacesmuchoftheOB1tocollect. 
Lanes 7 and 8 in figure 15 show a gel sample on the flowthrough and elution. In the
flowthrough,lane7,therearealotofproteinssincetheseareallproteinsthatdonotbindtothe
matrix,howeverintheelution,lane8,thereisonlyoneclearband.Thisbandisatthe17.7kDa
mark which is wheretheOB1proteinshouldbe.Now,theOB1proteinhasbeenisolatedfrom
the cell material, however it is clear that the elution (whichcontainsOB1)iscontaminatedby
otherproteins.Inlane8therearemultiplebandsofproteinsnotjustatthe17.7kDamark.Toget
rid of these proteins of different sizes another technique calledsizeexclusionchromatography
(SEM)isused. 
SEM is a method which separates the proteins within the elution based on size. To
accomplishSEM,FastLiquidProteinChromatography(FPLC)wasused.TheFPLCmachineis
abletoseparateaproteinmixturebasedonsizebecauseoneofitsmajorcomponentsisacolumn
that consists of amatrixofbeadsinwhichthespacesbetweenthemgetssmallerfurtherdown.



Asaresult,biggerproteinscomeoffthecolumnfirstwhilesmallerproteinscomeofflatersince
theytravelfurtherthroughthematrix. 
To use the FPLC machine a FPLC buffer, specific for the protein, was attached to the
machine(thisisthebuffertheproteinselutedoffof).Theproteinelutionwasthenconcentrated
down to 5 mL using the and then injected into the FPLC machine. As the machine runs, it
separates out the proteins within the 5 mL. To quantify the amountofproteincomingoffthe
column as time passes, the separated sample runs through apartofthemachinethatmeasures
UVabsorbanceat280nm.Atthiswavelength,aromaticresidueswithintheproteinsabsorbthe
mostamountoflight.Thus,theamountofabsorbanceat280nmisdirectlyrelatedtotheamount
ofproteineluted. 


Figure 16 shows the UV absorbance chromatogram of the FPLC run for OB1. The very first
peakofproteinscomingoffistheaggregatepeakwhichincludesanyaggregatedOB1andvery



large proteins. The elution at 80mL is where OB1 came off the column. The elution was
collected in 2mL fractions. Figure 17 shows an
SDS-PAGE gel of the aggregate peak and the
elutionat80mLs.Thegelcrealyshowsthatthe
elution contains OB1 since there are multiple
bandsatthe17.7kDamark. 

To calculate the concentration of OB1 that
was eluted. The protein was diluted in 8M
Guanidine Hydrochloride in a 1:2 ratio and the
absorbance at 280 nm was captured. The molar concentration of protein was then calculated
using Beer-Lambert's law: A=ecl.
TheconcentrationofOB1is12μM. 
OB2: 
ThesameprocesstopurifyOB1was
usedtopurifyOB2aswell.Figure18
shows the SDS-PAGE gel of the
different stepswithinthepurification
process. OB2 is 16.7 kDa, and the
protein is present in the post
induction (lane 3), sonication (lane
4), soluble fraction(Lane5),andthe
elution(lane8). 



Figure19showstheFPLCchromatogramofOB2,theproteinelutesataround80mLjust
likeOB1whichmakessensesincebothproteinsareverysimilarinsize. 


An SDS-PAGE gel oftheaggregatepeakandelutionisshowninfigure21.The
fractions eluted at 80mL show that
OB2hasbeensuccessfullyseparated
fromtherestofthesolution. 
The concentration of OB2
wascalculatedthesamewayasOB1
andis11μM. 
OB3: 
OB3 was first purified using
themethoddescribedabove. Figure
21showstheSDS-PAGEgelforthe
purification of OB3. An interesting



thingtonoteaboutthisfigureistheOB3ispresentinthepostinductionsample(lane3)andthe
sonication sample (lane 4) which is as
expected. However OB3 is not present in
thesolubleorinsolublefractionsofthecell
latsaye (lanes 5 & 6). The most possible
explanation for this is that OB3 is actually
in the insoluble fraction. Running a gel
samplefortheinsolublefractionistoughto
go since the insoluble pellet needs to be
resuspendedinabuffer.Sinceitisinsoluble
this isdifficulttodo.ButthefactthatOB3
was not present in the soluble fraction
shows that it most likely precipitated out of solution.
BecauseOB3isasub-domain,itcouldbethatitdoesnot
foldproperly,anditaggregatesoutofsolution. 
A potential fix for this problem is to go about
purifyingOB3usingadifferentmethod.Thisnewmethod
wouldinvolvedenaturingOB3andthenpurifyingitoutof
solution. Conceptually, this is very similar to a normal
purification sinceadenaturedproteinstillhasanexposed
His-tag that can bindtotheCo2+resin.Furthermore,the
same buffers are used, however both the1xLysisBuffer
andelutionbuffercontained6MGuHCl.GuHCldenature



proteins by disputing the hydrogen bondsthatholdaprotein'ssecondarystructure.Asaresult,
denaturedproteinsaremuchmoresoluble.Figure22showsanSDS-PAGEgelofthepurification
ofOB3underdenaturingconditions.OB3isnowpresentinallthestepsitwouldbeexpectedto

be in. OB3 is present in post induction sample (lane2),sonication(lane3),solublecelllysate
fraction(lane4),andthelution(lane7).Allofthesebandsareatthe16.8kDamarkwhichisthe
sizeofOB3. 
Even though OB3 was successfully eluted it is still denatured. To renature OB3, the
guanidine was slowly removed from solution using a dialysis
tubing. 
The elution wasthenconcentratedto5mLandthenloaded
ontotheFPLCmachineforsizeexclusion.Figure23showstheUV
absorbance chromatogram of theFPLCrunusingtheOB3elution
fromdenaturingpurificationconditions.OB3shouldhaveelutedat
around80mL(sincethisiswhereproteinsthesizeofOB3eluteon



this FPLC column, however there is no peak there. Figure 24showsanSDS-PAGEgelofthe
aggregatepeakandclearlyOB3ispresentwithinthispeak.SinceOB3aggregatesundernormal
anddenaturingconditionsOB3istoounstabletobepurified. 
OB12: 
OB12 was purified under normal purification conditions. Figure 25 shows the
SDS-PAGEgelofthedifferentstepswithinthepurificationprocess.OB12isa35.7kDaprotein
and boxed in red, figure 25 shows the presence of OB12 in each step of purification. Lane 5
shows the gel sample of the insoluble fraction and it seems that much of the OB12proteinis
present.InfactthereisnoOB12presentintheelution,showingthattheproteinwaslostbefore
theelution(potentiallyintheinsolublefraction). 
The denaturing protocol using 6M GuHCl
wasnotusedbecauseOB12istoolarge.Thisprotocolis
only

recommended

for

proteins less than 18 kDa
sinceproteinsbiggerthanthis
are more likely toimproperly
refold.

However,

to

potentially increase the yield
of OB12,thepurificationwas
repeated using a 1.5M salt
concentration. This is because in the insoluble fraction, larger
fragmentsofDNAarepresent.Thus,itwashypothesizedthatOB12waspresentintheinsoluble
fractionbecauseitwasbindingtoDNA.ThestrengthofproteinDNAinteractionsreducesinthe



presenceofhighsaltconcentrationduetolowerelectrostaticinteractions.However,thisdidnot
increase the yield of OB12 as it still was not present in the elution as seen in the lastlaneof
Figure26. 
OB123: 
OB123 was first purified under normal conditions. The SDS-PAGE gel in Figure 27
shows the steps of the OB123 purification. This protein is55kDa,howevertherearenoclear
bands nearthisareaonthegelindicatingthatOB123wasnotsuccessfullypurified.Infact,the
elution (lane 7) itself doesnotcontainanyOB123protein.Thisisquitesurprisingsinceitwas
expected that OB123 would be more stable than the other constructs since it contains all
individualdomains. 
OB123couldhavepotentiallyaggregatedthusitisnot
binding to the Co2+ matrix. Due to this problem, the
denaturing protocol for purifying protein using 6M
GuHClwasused.Thisprotocolisonlyrecommended
forproteinsthatarelessthan18kDainsize.However
since sub domains
(like the individual
OB

folds)

fold

independently/separately from oneanother,itwashypothesized
that usingthisprotocolforpurifyingaproteinasbigasOB123
wasjustifiable.FromtheSDS-PAGEgelshowninFigure28,it



isevidentthatthedenaturationpurificationprotocolwasnotsuccessful.OB123wasnotpresent
intheelution(oranyotherlane). 
OB23: 
OB123 was first purified under normal conditions. The SDS-PAGE gel in Figure 29
shows the steps of the OB123 purification. This protein is55kDa,howevertherearenoclear
bands nearthisareaonthegelindicatingthatOB123wasnotsuccessfullypurified.Infact,the
elution (lane 7) itself does not contain any OB123 protein. However due to time constraints
optimizationof 


EMSA: 
The electrophoretic mobility shift assay
tests the DNA binding affinity of a
protein for DNA. Figure 30 shows how
theseassaysaccomplishthis.Eachlaneis
loaded with DNA and increasing
concentrations of protein. The protein
binds to DNA, and as a result it has a
higher molecular weight than the
unbounded DNA. Due to this the bands
on top showed DNA bounded byprotein
while those on the bottom show unbounded DNA. NoticethatthebandsoftheunboundDNA



get lighter and the bands of the bounded DNA get darker as the concentration of protein
increases.Thisiswhatshouldbeexpected. 

Figure 31shows the best
EMSA gel that this study could
produce. Unfortunately there is Not
asmuchseparationbetweenthebands
and The control band of unbounded
DNA and no protein is not present.
However the binding reactions used
to make this gel can be optimizedto
produceabettergelwithahigherresolution. 






The table below shows the binding reaction concentrations for this gel. The methods
sectiondescribesmoreclearlywhateachreagentwas.Thoughthisgelisnotideal,itdoesshow
thatOB1doesbindtossDNAwhichisimportantinunderstandingwhereneartheDSBoverhang
theproteinbindsto. 
Though there were a lot of optimization steps needed to get the EMSA results shown,
improving on these conditions like the runtime and concentrations of the DNA, protein, and
bindingreagentswillallplayaroleinincreasingtheresolutionofthegel.
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